Ralimetinib dimesylate
Product Specifications
CAS Number
862507-23-1
Target
Autophagy, p38 MAPK, Apoptosis
Related Pathways
Apoptosis, Autophagy, MAPK
Purity
0.9938
Bioactivity
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
Smiles
CS(O)(=O)=O.CS(O)(=O)=O.CC(C)(C)Cn1c(N)nc2ccc(nc12)-c1[nH]c(nc1-c1ccc(F)cc1)C(C)(C)C
Molecular Formula
C24H29FN6·2CH4O3S
Molecular Weight
612.74
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402074-100 1x 100 µL
Prostate Specific Acid Phosphatase (PSAP) (rACPP/1338), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
